U.S. Research Roundup-Accendra Health, Celestica, Sionna Therapeutics
CLS•Highlights from the roundup
| * Accendra Health Inc ACH.N: Baird cuts to neutral rating |
| * Celestica Inc CLS.N: Scotiabank resumes coverage with sector outperform rating |
| * N-Able Inc NABL.N: RBC cuts to sector perform from outperform |
| * Powerfleet Inc AIOT.O: Raymond James cuts to market perform from outperform |
| * Sionna Therapeutics Inc SION.O: Jonestrading cuts to hold rating |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
Wall Street analysts revise ratings and price targets
Aug. 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Accendra Health, Celestica and Sionna Therapeutics, on Tuesday.
